Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1996 Aug;55(8):491–493. doi: 10.1136/ard.55.8.491

Clinical trials in osteoarthritis.

L M March, P M Brooks
PMCID: PMC1010222  PMID: 8774173

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ayral X., Dougados M., Listrat V., Bonvarlet J. P., Simonnet J., Poiraudeau S., Amor B. Chondroscopy: a new method for scoring chondropathy. Semin Arthritis Rheum. 1993 Apr;22(5):289–297. doi: 10.1016/s0049-0172(05)80008-3. [DOI] [PubMed] [Google Scholar]
  2. Badley E. M., Tennant A. Impact of disablement due to rheumatic disorders in a British population: estimates of severity and prevalence from the Calderdale Rheumatic Disablement Survey. Ann Rheum Dis. 1993 Jan;52(1):6–13. doi: 10.1136/ard.52.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Badley E. The impact of musculoskeletal disorders on the Canadian population. J Rheumatol. 1992 Mar;19(3):337–340. [PubMed] [Google Scholar]
  4. Brooks P. M., March L. M. New insights into osteoarthritis. Med J Aust. 1995 Oct 2;163(7):367–369. doi: 10.5694/j.1326-5377.1995.tb124631.x. [DOI] [PubMed] [Google Scholar]
  5. Buckland-Wright J. C. Quantitative radiography of osteoarthritis. Ann Rheum Dis. 1994 Apr;53(4):268–275. doi: 10.1136/ard.53.4.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dieppe P., Cushnaghan J., Jasani M. K., McCrae F., Watt I. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol. 1993 Jul;32(7):595–600. doi: 10.1093/rheumatology/32.7.595. [DOI] [PubMed] [Google Scholar]
  7. Dieppe P., Cushnaghan J., Young P., Kirwan J. Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy. Ann Rheum Dis. 1993 Aug;52(8):557–563. doi: 10.1136/ard.52.8.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dougados M. Clinical assessment of osteoarthritis in clinical trials. Curr Opin Rheumatol. 1995 Mar;7(2):87–91. doi: 10.1097/00002281-199503000-00003. [DOI] [PubMed] [Google Scholar]
  9. Felson D. T. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990 Dec;20(3 Suppl 1):42–50. doi: 10.1016/0049-0172(90)90046-i. [DOI] [PubMed] [Google Scholar]
  10. Huskisson E. C., Berry H., Gishen P., Jubb R. W., Whitehead J. Effects of antiinflammatory drugs on the progression of osteoarthritis of the knee. LINK Study Group. Longitudinal Investigation of Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis. J Rheumatol. 1995 Oct;22(10):1941–1946. [PubMed] [Google Scholar]
  11. Hutton C. W., Vennart W. Osteoarthritis and magnetic resonance imaging: potential and problems. Ann Rheum Dis. 1995 Apr;54(4):237–243. doi: 10.1136/ard.54.4.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lequesne M., Brandt K., Bellamy N., Moskowitz R., Menkes C. J., Pelletier J. P., Altman R. Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol Suppl. 1994 Sep;41:65–73. [PubMed] [Google Scholar]
  13. Lohmander L. S. Molecular markers to monitor outcome and intervention in osteoarthritis (promises, promises...) Br J Rheumatol. 1995 Jul;34(7):599–601. doi: 10.1093/rheumatology/34.7.599. [DOI] [PubMed] [Google Scholar]
  14. March L., Irwig L., Schwarz J., Simpson J., Chock C., Brooks P. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ. 1994 Oct 22;309(6961):1041–1046. doi: 10.1136/bmj.309.6961.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Paulus H. E., Bulpitt K. J. Clinical trials of osteoarthritis therapies. Br J Rheumatol. 1993 Jul;32(7):529–531. doi: 10.1093/rheumatology/32.7.529. [DOI] [PubMed] [Google Scholar]
  16. Rashad S., Revell P., Hemingway A., Low F., Rainsford K., Walker F. Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthritis. Lancet. 1989 Sep 2;2(8662):519–522. doi: 10.1016/s0140-6736(89)90651-x. [DOI] [PubMed] [Google Scholar]
  17. Sangha O., Liang M. H. Assessment outcomes of clinical drug trials in osteoarthritis. Curr Opin Rheumatol. 1995 Jul;7(4):352–355. doi: 10.1097/00002281-199507000-00015. [DOI] [PubMed] [Google Scholar]
  18. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  19. Theiler R., Ghosh P., Brooks P. Clinical, biochemical and imaging methods of assessing osteoarthritis and clinical trials with agents claiming 'chondromodulating' activity. Osteoarthritis Cartilage. 1994 Mar;2(1):1–23. doi: 10.1016/s1063-4584(05)80002-0. [DOI] [PubMed] [Google Scholar]
  20. Williams H. J., Ward J. R., Egger M. J., Neuner R., Brooks R. H., Clegg D. O., Field E. H., Skosey J. L., Alarcón G. S., Willkens R. F. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum. 1993 Sep;36(9):1196–1206. doi: 10.1002/art.1780360904. [DOI] [PubMed] [Google Scholar]
  21. Wollheim F. A. New insight into joint damage from analysis of released biochemical markers. Br J Rheumatol. 1994 Jan;33(1):1–2. doi: 10.1093/rheumatology/33.1.1. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES